Search / Trial NCT06617364

MSOT for Assessment of Intestinal Transit Time in Lactose Intolerance Patients

Launched by UNIVERSITY OF ERLANGEN-NÜRNBERG MEDICAL SCHOOL · Sep 24, 2024

Trial Information

Current as of October 07, 2024

Not yet recruiting

Keywords

Msot Lactose Intolerance Pediatric Icg Gastrointestinal Transit

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Written informed consent of the subject
  • * Written informed consent of the subject\'s legal guardian
  • * Suspicion or diagnosis of lactose intolerance
  • * Age 6 to 18 years
  • Exclusion Criteria:
  • * Pregnancy
  • * Breastfeeding mothers
  • * Tattoo in the examination area
  • * Subcutaneous fat tissue over 3 cm
  • * Known hypersensitivity to ICG, sodium iodide, or iodine
  • * Hyperthyroidism, focal or diffuse thyroid autonomy
  • * Recent treatment for thyroid function assessment involving radioactive iodine (within two weeks before or after the study)
  • * Impaired renal function
  • * Use of the following medications: beta-blockers, anticonvulsants, cyclopropane, bisulfite compounds, haloperidol, heroin, meperidine, metamizole, methadone, morphine, nitrofurantoin, opium alkaloids, phenobarbital, phenylbutazone, probenecid, rifamycin, any injection containing sodium bisulfite

About University Of Erlangen Nürnberg Medical School

The University of Erlangen-Nürnberg Medical School is a prestigious institution dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. Renowned for its interdisciplinary approach, the medical school fosters collaboration among experts in various fields, enabling the development of cutting-edge therapies and treatment protocols. With a commitment to ethical standards and patient safety, the institution actively contributes to the global medical community by conducting rigorous clinical studies aimed at enhancing the understanding and management of diverse health conditions.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0